| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/17/1992 | EP0259499B1 Anti-allergic agent |
| 06/17/1992 | CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/17/1992 | CN1061907A Suspendible composition and process for prepairng same |
| 06/16/1992 | US5122535 Method of solubilizing melatonine in water |
| 06/16/1992 | US5122511 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| 06/16/1992 | CA1303607C 6.alpha.-METHYLCORTICOIDS AND THEIR MANUFACTURE AND USE |
| 06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
| 06/16/1992 | CA1303504C Pharmaceutical formulation containing acrivastine |
| 06/14/1992 | WO1992010201A1 Pharmaceutical compositions for the treatment of b-cell malignancies |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098509A1 Pharmaceutical compositions for the treatment of b-cell malignancies |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/13/1992 | WO1992010469A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/13/1992 | CA2094247A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
| 06/11/1992 | WO1992009598A1 New pyridine derivatives, methods of preparing them and their use as drugs |
| 06/11/1992 | WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 06/11/1992 | CA2099603A1 New pyridine derivatives, processes for their preparation and use as medicaments |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
| 06/11/1992 | CA2057292A1 Labelled, modified oligonucleotides |
| 06/10/1992 | EP0489548A1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | EP0489547A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | CN1061775A Hydroxamic acid and n-hydroxyurea derivatives and their use |
| 06/09/1992 | US5120842 Immunosuppresive activity, antitumor agents, fungicides |
| 06/09/1992 | US5120760 Administering gamma-linolenic acid and stearidonic acid |
| 06/09/1992 | US5120758 Treating allergic, inflammatory, cardiovascular, pulmonary, arthritic, cutaneous disorders |
| 06/09/1992 | US5120747 Platelet activating factor antagonists |
| 06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 06/09/1992 | US5120743 Cyclic anthranilic acid acetic acid derivatives and process for the preparation |
| 06/09/1992 | US5120727 Rapamycin dimers |
| 06/09/1992 | US5120725 Antibody inhibitors |
| 06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
| 06/09/1992 | CA1303057C P-aminophenols, derivatives thereof and method of use |
| 06/09/1992 | CA1303049C 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound |
| 06/07/1992 | WO1992010205A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | WO1992010096A1 Compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | CA2097826A1 Compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | CA2097825A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/05/1992 | WO1992010202A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 06/05/1992 | CA2056810A1 Extract from mixture of phellodendron and seed of croton, method for the same and drug containing the same |
| 06/04/1992 | DE4038335A1 Neue pyridinderivate, verfahren zu ihrer herstellung und verwendung als arzneimittel Last pyridine derivatives, process for their production and use as a drug |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488602A1 Aryl derivatives |
| 06/03/1992 | EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same |
| 06/03/1992 | EP0488009A2 Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them |
| 06/03/1992 | EP0488008A1 Heterocyclic substituted piperazinoalkylbenzoxazine and -thiazine compounds, process for their preparation and therapeutic drugs containing them |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0487623A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs |
| 06/03/1992 | EP0487593A1 Macrocyclic compounds |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | EP0487525A1 Tuftsin analogs |
| 06/03/1992 | CN1061594A Hydroxyalkylquineline ether acids as leakotaiene antagonists |
| 06/02/1992 | US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases |
| 06/02/1992 | US5118701 Antiischemic agents, anticoagulants |
| 06/02/1992 | US5118700 Indole derivatives and compositions for their use in medicaments |
| 06/02/1992 | US5118677 For treating transplant rejection, host vs. draft disease, autoimmune diseases and inflammations; antibody inhibitors |
| 06/02/1992 | CA1302424C Phenolic thioethers as inhibitors of 5-lipoxygenase |
| 06/02/1992 | CA1302412C 5-chloro-s-triazolo[4,3-a]pyridine-7-carboxylic acids |
| 06/02/1992 | CA1302410C Dihydropyridine anti-allergic and anti-inflammatory agents |
| 06/02/1992 | CA1302279C Solid dispersion composition of fr-900506 substance |
| 05/31/1992 | WO1992009276A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
| 05/31/1992 | CA2095334A1 Pharmaceutical compositions |
| 05/31/1992 | CA2056800A1 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 05/31/1992 | CA2056723A1 Use of xanthines for the preparation of a medicament having immuno supressing activity |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008708A1 Biologically active amines |
| 05/29/1992 | WO1992008701A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008700A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008688A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008484A1 Mycobacterium vaccae in the treatment of uveitis |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2055530A1 Aryl derivatives |
| 05/28/1992 | WO1992009299A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/28/1992 | CA2072983A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/27/1992 | EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them |
| 05/27/1992 | EP0486809A2 Use of suramin against TNF-related diseases |
| 05/27/1992 | DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use |
| 05/27/1992 | CN1061413A Pharmaceutical compounds |
| 05/27/1992 | CN1061409A Compounds, pharmaceutical compositions containing them and process for preparing same |
| 05/27/1992 | CN1061408A Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 05/27/1992 | CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116863 Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof |
| 05/26/1992 | US5116816 Immunosuppressants, antiinflammatory, parasiticides |
| 05/26/1992 | CA1301770C Isothiuronium salts |
| 05/26/1992 | CA1301762C Dichloroaniline derivatives |
| 05/25/1992 | CA2056009A1 Heterocyclically substituted piperazinoalkylbenzoxazine and piperazinolkylbenzothiazine compounds, processes for preparing them, and medicaments containing them |
| 05/24/1992 | WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 05/24/1992 | CA2056008A1 Benzoselenazolinone derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 05/22/1992 | WO1992009203A1 Tnf inhibitors |
| 05/22/1992 | CA2096623A1 Tnf inhibitors |
| 05/20/1992 | EP0486211A1 Isoquinoline derivatives |
| 05/20/1992 | EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition |
| 05/20/1992 | EP0485984A2 Diarylmethoxypiperidine derivatives |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |